{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T05:02:15Z","timestamp":1789794135600,"version":"4.0.1"},"reference-count":99,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570867"],"award-info":[{"award-number":["82570867"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"award":["82570867"],"award-info":[{"award-number":["82570867"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>PRDM16 is a PR domain-containing epigenetic regulator with intrinsic histone methyltransferase activity and scaffolding interactions with corepressor complexes such as CtBP1\/2. Beyond its well-established roles in adipose biology, emerging evidence positions PRDM16 as a central node linking chromatin regulation, metabolic control, and cell survival in the kidney, making it a multimodal pharmacological target. In acute kidney injury, PRDM16 functions as an endogenous protective hub that simultaneously suppresses ferroptosis, apoptosis, and pyroptosis through distinct downstream pathways. In chronic and diabetic kidney disease, TGF-\u03b2\/Smad-driven silencing or promoter hypermethylation of PRDM16 disrupts PGC-1\u03b1-dependent mitochondrial integrity and podocyte insulin signaling, offering opportunities for epigenetic reactivation strategies and gene therapy. In clear cell renal cell carcinoma, PRDM16 exhibits a striking duality: epigenetically silenced by CpG island hypermethylation within cancer cells yet upregulated in peritumoral adipocytes to drive a browning-associated, pro-metastatic secretome, defining a unique pharmacological dichotomy that calls for cell-type-selective interventions. This review synthesizes the molecular architecture, isoform diversity, and disease-stage-specific regulation of PRDM16 and evaluates the pharmacological toolset currently available: the expression-inducing natural product formononetin, adenoviral and lentiviral gene delivery systems, and platelet membrane-coated or PLGA-based nanoparticles (PNPs) that enable kidney-targeted delivery. We further discuss key pharmacological challenges, including the need for isoform-selective modulation to avoid oncogenic short-form upregulation, cell-type-specific targeting within the nephron and tumor microenvironment, and the development of pharmacodynamic biomarkers for clinical translation. By integrating mechanistic insights with a drug discovery perspective, this review provides a comprehensive pharmacological framework for targeting PRDM16 to restore renal homeostasis and halt disease progression.<\/jats:p>","DOI":"10.3390\/ph19091469","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:50:27Z","timestamp":1789566627000},"page":"1469","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["PRDM16 as a Multifaceted Pharmacological Target in Kidney Diseases: From Epigenetic Mechanisms to Therapeutic Strategies"],"prefix":"10.3390","volume":"19","author":[{"given":"Qiuyu","family":"Dai","sequence":"first","affiliation":[{"name":"Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6140-2511","authenticated-orcid":false,"given":"Shu","family":"Rong","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000360668","article-title":"Cell therapy for kidney injury: Different options and mechanisms-kidney progenitor cells","volume":"126","author":"Osafune","year":"2014","journal-title":"Nephron Exp. Nephrol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Turner, J.E., Rickassel, C., Healy, H., and Kassianos, A.J. (2019). Natural Killer Cells in Kidney Health and Disease. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00587"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"102980","DOI":"10.1016\/j.autrev.2021.102980","article-title":"Interplay of immune and kidney resident cells in the formation of tertiary lymphoid structures in lupus nephritis","volume":"20","author":"Jamaly","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1016\/S2214-109X(24)00050-0","article-title":"The major global burden of chronic kidney disease","volume":"12","author":"Jadoul","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2521457","DOI":"10.1080\/0886022X.2025.2521457","article-title":"Kidney diseases and single-cell sequencing research: A bibliometric analysis from 2015 to 2024","volume":"47","author":"Li","year":"2025","journal-title":"Ren. Fail."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e202402719","DOI":"10.26508\/lsa.202402719","article-title":"PRDM16 determines specification of ventricular cardiomyocytes by suppressing alternative cell fates","volume":"7","author":"Mahy","year":"2024","journal-title":"Life Sci. Alliance"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/s44161-025-00737-8","article-title":"PRDM16 regulates smooth muscle cell identity and atherosclerotic plaque composition","volume":"4","author":"Tan","year":"2025","journal-title":"Nat. Cardiovasc. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/cvr\/cvaf089","article-title":"PRDM16, a new kid on the block in cardiovascular health and disease","volume":"121","author":"Kemps","year":"2025","journal-title":"Cardiovasc. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cmet.2007.06.001","article-title":"Transcriptional control of brown fat determination by PRDM16","volume":"6","author":"Seale","year":"2007","journal-title":"Cell Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nature07182","article-title":"PRDM16 controls a brown fat\/skeletal muscle switch","volume":"454","author":"Seale","year":"2008","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13072-023-00519-1","article-title":"The functions of SET domain bifurcated histone lysine methyltransferase 1 (SETDB1) in biological process and disease","volume":"16","author":"Luo","year":"2023","journal-title":"Epigenet. Chromatin"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1101\/gad.252809.114","article-title":"PRDM16 enhances nuclear receptor-dependent transcription of the brown fat-specific Ucp1 gene through interactions with Mediator subunit MED1","volume":"29","author":"Iida","year":"2015","journal-title":"Genes. Dev."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kinameri, E., Inoue, T., Aruga, J., Imayoshi, I., Kageyama, R., Shimogori, T., and Moore, A.W. (2008). Prdm proto-oncogene transcription factor family expression and interaction with the Notch-Hes pathway in mouse neurogenesis. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003859"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/ncb2101","article-title":"Prdm16 promotes stem cell maintenance in multiple tissues, partly by regulating oxidative stress","volume":"12","author":"Chuikov","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1182\/blood-2011-07-365080","article-title":"Quantitative trait mapping reveals a regulatory axis involving peroxisome proliferator-activated receptors, PRDM16, transforming growth factor-\u03b22 and FLT3 in hematopoiesis","volume":"118","author":"Avagyan","year":"2011","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"103417","DOI":"10.1016\/j.redox.2024.103417","article-title":"PRDM16 suppresses ferroptosis to protect against sepsis-associated acute kidney injury by targeting the NRF2\/GPX4 axis","volume":"78","author":"Zheng","year":"2024","journal-title":"Redox Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/s41418-025-01477-9","article-title":"PRDM16 deficiency promotes podocyte injury by impairing insulin receptor signaling","volume":"32","author":"Yuan","year":"2025","journal-title":"Cell Death Differ."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.acthis.2009.09.006","article-title":"PRDM16 expression in the developing mouse embryo","volume":"113","author":"Horn","year":"2011","journal-title":"Acta Histochem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1158\/1078-0432.CCR-07-0305","article-title":"PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer","volume":"13","author":"Watanabe","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1242\/dev.070110","article-title":"The Prdm family: Expanding roles in stem cells and development","volume":"139","author":"Hohenauer","year":"2012","journal-title":"Development"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.molcel.2023.12.007","article-title":"Pioneer and PRDM transcription factors coordinate bivalent epigenetic states to safeguard cell fate","volume":"84","author":"Matsui","year":"2024","journal-title":"Mol. Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1128\/MCB.00498-13","article-title":"The PR\/SET domain zinc finger protein Prdm4 regulates gene expression in embryonic stem cells but plays a nonessential role in the developing mouse embryo","volume":"33","author":"Bogani","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Deng, S., Li, H., Guo, C., Zou, J., and Zhang, L. (2026). PRDM Family Proteins in Immune Regulation: Epigenetic Control and Implications in Immune-Related Diseases. Biology, 15.","DOI":"10.3390\/biology15100801"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Casamassimi, A., Rienzo, M., Di Zazzo, E., Sorrentino, A., Fiore, D., Proto, M.C., Moncharmont, B., Gazzerro, P., Bifulco, M., and Abbondanza, C. (2020). Multifaceted Role of PRDM Proteins in Human Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072648"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1038\/s41467-025-56991-8","article-title":"Maternal PRDM10 activates essential genes for oocyte-to-embryo transition","volume":"16","author":"Seah","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/path.1752","article-title":"PRDM1\/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage","volume":"206","author":"Cattoretti","year":"2005","journal-title":"J. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bcmd.2014.01.002","article-title":"The role of EVI1 in myeloid malignancies","volume":"53","author":"Glass","year":"2014","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tig.2017.12.017","article-title":"PRDM9 and Its Role in Genetic Recombination","volume":"34","author":"Paigen","year":"2018","journal-title":"Trends Genet."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"112969","DOI":"10.1016\/j.yexcr.2021.112969","article-title":"Role of Mel1\/Prdm16 in bone differentiation and morphology","volume":"410","author":"Igawa","year":"2022","journal-title":"Exp. Cell Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.molcel.2016.03.010","article-title":"PRDM16 Suppresses MLL1r Leukemia via Intrinsic Histone Methyltransferase Activity","volume":"62","author":"Zhou","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ydbio.2020.02.006","article-title":"The conserved and divergent roles of Prdm3 and Prdm16 in zebrafish and mouse craniofacial development","volume":"461","author":"Shull","year":"2020","journal-title":"Dev. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1101\/gad.1666108","article-title":"Regulation of the brown and white fat gene programs through a PRDM16\/CtBP transcriptional complex","volume":"22","author":"Kajimura","year":"2008","journal-title":"Genes. Dev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.1038\/s41467-023-43021-8","article-title":"Transcriptional repression of beige fat innervation via a YAP\/TAZ-S100B axis","volume":"14","author":"Huang","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41586-022-05067-4","article-title":"Post-translational control of beige fat biogenesis by PRDM16 stabilization","volume":"609","author":"Wang","year":"2022","journal-title":"Nature"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"112407","DOI":"10.1016\/j.mce.2024.112407","article-title":"PRDM16 in thermogenic adipocytes mediates an inter-organ protective signaling against alcohol-associated liver disease","volume":"595","author":"Liu","year":"2025","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.stem.2019.08.017","article-title":"PRDM16 Maintains Homeostasis of the Intestinal Epithelium by Controlling Region-Specific Metabolism","volume":"25","author":"Stine","year":"2019","journal-title":"Cell Stem Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1172\/JCI99862","article-title":"PRDM16 isoforms differentially regulate normal and leukemic hematopoiesis and inflammatory gene signature","volume":"128","author":"Corrigan","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1182\/blood.2018888255","article-title":"PRDM16s transforms megakaryocyte-erythroid progenitors into myeloid leukemia-initiating cells","volume":"134","author":"Hu","year":"2019","journal-title":"Blood"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"43112","DOI":"10.1074\/jbc.M111.252775","article-title":"Peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1) induces PPAR\u03b3 coactivator 1\u03b1 (PGC-1\u03b1) gene expression and contributes to thermogenic activation of brown fat: Involvement of PRDM16","volume":"286","author":"Hondares","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/nature08262","article-title":"Initiation of myoblast to brown fat switch by a PRDM16-C\/EBP-beta transcriptional complex","volume":"460","author":"Kajimura","year":"2009","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7699","DOI":"10.7150\/thno.77102","article-title":"SOX4 promotes beige adipocyte-mediated adaptive thermogenesis by facilitating PRDM16-PPAR\u03b3 complex","volume":"12","author":"Shen","year":"2022","journal-title":"Theranostics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.neuron.2018.04.033","article-title":"The Epigenetic State of PRDM16-Regulated Enhancers in Radial Glia Controls Cortical Neuron Position","volume":"98","author":"Baizabal","year":"2018","journal-title":"Neuron"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1182\/blood-2010-08-300145","article-title":"Prdm16 is a physiologic regulator of hematopoietic stem cells","volume":"117","author":"Aguilo","year":"2011","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.exphem.2020.04.010","article-title":"Prdm3 and Prdm16 cooperatively maintain hematopoiesis and clonogenic potential","volume":"85","author":"McGlynn","year":"2020","journal-title":"Exp. Hematol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/ncb3411","article-title":"iPSC-derived cardiomyocytes reveal abnormal TGF-\u03b2 signalling in left ventricular non-compaction cardiomyopathy","volume":"18","author":"Kodo","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e010351","DOI":"10.1161\/CIRCHEARTFAILURE.122.010351","article-title":"Nonsense Variant PRDM16-Q187X Causes Impaired Myocardial Development and TGF-\u03b2 Signaling Resulting in Noncompaction Cardiomyopathy in Humans and Mice","volume":"16","author":"Sun","year":"2023","journal-title":"Circ. Heart Fail."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41420-024-02214-w","article-title":"Sleep restriction exacerbates cardiac dysfunction in diabetic mice by causing cardiomyocyte death and fibrosis through mitochondrial damage","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e191458","DOI":"10.1172\/jci.insight.191458","article-title":"PRDM16 acts as a therapeutic downstream target of TGF-\u03b2 signaling in chronic kidney disease","volume":"10","author":"Yuan","year":"2025","journal-title":"JCI Insight"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/nar\/gky1192","article-title":"Direct interaction between the PRDM3 and PRDM16 tumor suppressors and the NuRD chromatin remodeling complex","volume":"47","author":"Ivanochko","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e20191005","DOI":"10.1084\/jem.20191005","article-title":"PRDM16 suppresses HIF-targeted gene expression in kidney cancer","volume":"217","author":"Kundu","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e737","DOI":"10.1002\/mco2.737","article-title":"Overexpression of PRDM16 attenuates acute kidney injury progression: Genetic and pharmacological approaches","volume":"5","author":"Li","year":"2024","journal-title":"MedComm"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00018-025-05666-0","article-title":"PRDM16 suppresses pyroptosis to attenuate the progression of AKI caused by rhabdomyolysis via upregulation of USP10","volume":"82","author":"Han","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/cc11454","article-title":"Diagnosis, evaluation, and management of acute kidney injury: A KDIGO summary (Part 1)","volume":"17","author":"Kellum","year":"2013","journal-title":"Crit. Care"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41581-018-0052-0","article-title":"Global epidemiology and outcomes of acute kidney injury","volume":"14","author":"Hoste","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/S0140-6736(16)30240-9","article-title":"Recognition and management of acute kidney injury in the International Society of Nephrology 0by25 Global Snapshot: A multinational cross-sectional study","volume":"387","author":"Mehta","year":"2016","journal-title":"Lancet"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ki.1996.380","article-title":"Epidemiology of acute renal failure: A prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group","volume":"50","author":"Pascual","year":"1996","journal-title":"Kidney Int."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00134-022-06946-0","article-title":"Acute kidney injury","volume":"49","author":"Ostermann","year":"2023","journal-title":"Intensive Care Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.2215\/CJN.00710113","article-title":"World incidence of AKI: A meta-analysis","volume":"8","author":"Susantitaphong","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1164\/rccm.201604-0799OC","article-title":"Recovery after Acute Kidney Injury","volume":"195","author":"Kellum","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00018-025-05766-x","article-title":"PRDM16 acts as a homeostasis regulation factor to suppress the transition of AKI to CKD via upregulation of eukaryotic initiation factor 6","volume":"82","author":"Li","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"(2024). Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int., 105, S117\u2013S314.","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1038\/s41467-022-33824-6","article-title":"The gut microbe Bacteroides fragilis ameliorates renal fibrosis in mice","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.7150\/thno.85250","article-title":"Macrophage promotes fibroblast activation and kidney fibrosis by assembling a vitronectin-enriched microenvironment","volume":"13","author":"Peng","year":"2023","journal-title":"Theranostics"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41419-024-06780-w","article-title":"HOXD10 attenuates renal fibrosis by inhibiting NOX4-induced ferroptosis","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1182\/bloodadvances.2024014172","article-title":"Elritercept, a modified activin receptor IIA ligand trap, increased erythropoiesis and thrombopoiesis in a phase 1 trial","volume":"9","author":"Lachey","year":"2025","journal-title":"Blood Adv."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/s41419-022-05395-3","article-title":"Tubular \u03b2-catenin alleviates mitochondrial dysfunction and cell death in acute kidney injury","volume":"13","author":"Li","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41419-023-05557-x","article-title":"Aldehyde dehydrogenase 2 alleviates mitochondrial dysfunction by promoting PGC-1\u03b1-mediated biogenesis in acute kidney injury","volume":"14","author":"Li","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1186\/s12967-025-06852-1","article-title":"EphrinB2 alleviates tubulointerstitial fibrosis in diabetic kidney disease","volume":"23","author":"Ni","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Mak, R.H., Gunta, S., Oliveira, E.A., and Cheung, W.W. (2022). Growth Hormone Improves Adipose Tissue Browning and Muscle Wasting in Mice with Chronic Kidney Disease-Associated Cachexia. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232315310"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic Kidney Disease: Challenges, Progress, and Possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1038\/nrdp.2015.18","article-title":"Diabetic kidney disease","volume":"1","author":"Thomas","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41440-023-01496-4","article-title":"Angiotensin II type 1 receptor-associated protein deletion combined with angiotensin II stimulation accelerates the development of diabetic kidney disease in mice on a C57BL\/6 strain","volume":"47","author":"Taguchi","year":"2024","journal-title":"Hypertens. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s40620-020-00803-3","article-title":"Blood pressure reduction and RAAS inhibition in diabetic kidney disease: Therapeutic potentials and limitations","volume":"33","author":"Leoncini","year":"2020","journal-title":"J. Nephrol."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Han, Y.Z., Du, B.X., Zhu, X.Y., Wang, Y.Z., Zheng, H.J., and Liu, W.J. (2024). Lipid metabolism disorder in diabetic kidney disease. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1336402"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"103246","DOI":"10.1016\/j.redox.2024.103246","article-title":"Lactate drives epithelial-mesenchymal transition in diabetic kidney disease via the H3K14la\/KLF5 pathway","volume":"75","author":"Zhang","year":"2024","journal-title":"Redox Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s001250050616","article-title":"Patterns of renal injury in NIDDM patients with microalbuminuria","volume":"39","author":"Fioretto","year":"1996","journal-title":"Diabetologia"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e2306704","DOI":"10.1002\/advs.202306704","article-title":"Discovery of PRDM16-Mediated TRPA1 Induction as the Mechanism for Low Tubulo-Interstitial Fibrosis in Diabetic Kidney Disease","volume":"11","author":"Xu","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Tanase, D.M., Gosav, E.M., Anton, M.I., Floria, M., Seritean Isac, P.N., Hurjui, L.L., Tarniceriu, C.C., Costea, C.F., Ciocoiu, M., and Rezus, C. (2022). Oxidative Stress and NRF2\/KEAP1\/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives. Biomolecules, 12.","DOI":"10.3390\/biom12091227"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.7150\/thno.56598","article-title":"GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPK\u03b1 activity","volume":"11","author":"Lu","year":"2021","journal-title":"Theranostics"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"10018","DOI":"10.1038\/s41467-024-54089-1","article-title":"Profiling of insulin-resistant kidney models and human biopsies reveals common and cell-type-specific mechanisms underpinning Diabetic Kidney Disease","volume":"15","author":"Lay","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jama.2024.12848","article-title":"Renal Cell Carcinoma: A Review","volume":"332","author":"Rose","year":"2024","journal-title":"Jama"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(23)00922-4","article-title":"Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): A multicentre, randomised, open-label, phase 3 trial","volume":"402","author":"Pal","year":"2023","journal-title":"Lancet"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.chembiol.2017.09.009","article-title":"The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study","volume":"25","author":"Burslem","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"8687","DOI":"10.1038\/s41598-022-12746-9","article-title":"Renal peritumoral adipose tissue undergoes a browning process and stimulates the expression of epithelial-mesenchymal transition markers in human renal cells","volume":"12","author":"Ferrando","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1615\/CritRevEukaryotGeneExpr.2023048338","article-title":"Long Noncoding RNA MAGI2-AS3 Represses Cell Progression in Clear Cell Renal Cell Carcinoma by Modulating the miR-629-5p\/PRDM16 Axis","volume":"33","author":"Yan","year":"2023","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Yu, C., and Li, X. (2024). Kidney Aging and Chronic Kidney Disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25126585"},{"key":"ref_87","first-page":"2853","article-title":"Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor","volume":"6","author":"Patil","year":"2008","journal-title":"PLoS Biol."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Rodwell, G.E., Sonu, R., Zahn, J.M., Lund, J., Wilhelmy, J., Wang, L., Xiao, W., Mindrinos, M., Crane, E., and Segal, E. (2004). A transcriptional profile of aging in the human kidney. PLoS Biol., 2.","DOI":"10.1371\/journal.pbio.0020427"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"bbab274","DOI":"10.1093\/bib\/bbab274","article-title":"ADEIP: An integrated platform of age-dependent expression and immune profiles across human tissues","volume":"22","author":"Liu","year":"2021","journal-title":"Brief. Bioinform."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e01233","DOI":"10.1002\/advs.202501233","article-title":"PRDM16 Reduces Cellular Senescence by Upregulating GSTM1","volume":"12","author":"Yuan","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"153586","DOI":"10.1016\/j.tox.2023.153586","article-title":"Mirabegron alleviates acetic acid-induced colitis in rats: Role of adiponectin and GSTM1\/GSH detoxification pathway","volume":"494","author":"Mohamed","year":"2023","journal-title":"Toxicology"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Li, P., Li, D., Lu, Y., Pan, S., Cheng, F., Li, S., Zhang, X., Huo, J., Liu, D., and Liu, Z. (2024). GSTT1\/GSTM1 deficiency aggravated cisplatin-induced acute kidney injury via ROS-triggered ferroptosis. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1457230"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Navarro-Garc\u00eda, J.A., Gonz\u00e1lez-Lafuente, L., Fern\u00e1ndez-Velasco, M., Ruilope, L.M., and Ruiz-Hurtado, G. (2021). Fibroblast Growth Factor-23-Klotho Axis in Cardiorenal Syndrome: Mediators and Potential Therapeutic Targets. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.775029"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.amjcard.2023.06.031","article-title":"Post-contrast Acute Kidney Injury After Emergent and Elective Percutaneous Coronary Intervention (from the CREDO-Kyoto PCI\/CABG Registry Cohort 3)","volume":"202","author":"Kaneda","year":"2023","journal-title":"Am. J. Cardiol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"N\u00f8rg\u00e5rd, M., and Svenningsen, P. (2023). Acute Kidney Injury by Ischemia\/Reperfusion and Extracellular Vesicles. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242015312"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/CIRCRESAHA.122.321762","article-title":"Hypertension as Cardiovascular Risk Factor in Chronic Kidney Disease","volume":"132","author":"Burnier","year":"2023","journal-title":"Circ. Res."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Tan, J.M.E., Cheng, L., Calhoun, R.P., Weller, A.H., Drareni, K., Fong, S., Barbara, E., Lim, H.W., Xue, C., and Winter, H. (2025). PRDM16 controls smooth muscle cell fate in atherosclerosis. bioRxiv.","DOI":"10.1101\/2025.02.19.639186"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/CIRCRESAHA.120.318501","article-title":"Prdm16 Supports Arterial Flow Recovery by Maintaining Endothelial Function","volume":"129","author":"Craps","year":"2021","journal-title":"Circ. Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA-a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res. Integr. Peer Rev."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/9\/1469\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:20:46Z","timestamp":1789791646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/9\/1469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":99,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ph19091469"],"URL":"https:\/\/doi.org\/10.3390\/ph19091469","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]}}}